CASP3 and cancer: Concordant with the cancer cell survival advantage observed in vitro, MDA231BrM2-ΔIL13RA2 brain metastases showed significantly reduced cleaved caspase-3, an apoptotic marker, by immunohistochemistry (Fig. 3e).